HB 15 (see companion bill SB 326) – Hawaii

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=15&year=2022

Imposes dollar limits on specialty tiers in order to protect patients from unaffordable coinsurance or copayment amounts. Limits patients’ coinsurance or copayment fees for specialty tier drugs to $150 per month for up to a thirty-day period supply. Allow patients to request an exception to obtain a specialty drug that would not otherwise be available on a health plan formulary.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found